Profile picture

Associate Professor Mani Sadredini

University of Oslo, Oslo (Norway)
Follow
Logo ESC

Contributor content

CaMKII as a therapeutic target in catecholaminergic polymorphic ventricular tachycardia type 1
Presentation
CaMKII as a therapeutic target in catecholaminergic polymorphic ventricular tachycardia type 1
Read more
CaMKII as a therapeutic target in catecholaminergic polymorphic ventricular tachycardia type 1
Presentation
CaMKII as a therapeutic target in catecholaminergic polymorphic ventricular tachycardia type 1
Read more

ESC 365 is supported by

novartis Explore sponsored resources